Masui et al. [18], found that three proteins (LGALS1, PFN1 and YWHAZ) showed higher expression in primary ccRCC compared to normal adjacent tissue (NAT), and higher expression in metastatic lesions than in primary tumors. The gene discussed is BRD2; the disease is nonpapillary renal cell carcinoma.